Table 2.
Case series of hepatic resections with ablation performed for neuroendocrine liver metastases.
| Author | Year | N undergoing resection/ablation | Operative mortality (%) | Operative morbidity (%) | Symptom control (%) | Survival | |
|---|---|---|---|---|---|---|---|
| (1) | Mayo et al. [39] | 2010 | 339 | NA | NA | NA | 74% at 5 years |
| (2) | Glazer et al. [42] | 2010 | 172 | 0 | 22.1 | NA | 77.4% at 5 years 50.4% at 10 years |
| (3) | Strosberg et al. [108] | 2009 | 31 | NA | NA | NA | 75% at 5 years; median survival of 103 months |
| (4) | Touzios et al. [27] | 2005 | 19 | 5.2 | 42 | 95 | 72% at 5 years |
| (5) | Musunuru et al. [31] | 2006 | 13 | NA | NA | 100 | 83% at 3 years |